The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat

Neuropharmacology

Volumn 35, Issue 3, 1996, Pages 285-294

  Bristow, L J ^a   Cook, G P ^a   Gay, J C ^a   Kulagowski, J J ^a   Landon, L ^a   Murray, F ^a   Saywell, K L ^a   Young, L ^a   Hutson, P H ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Catecholamine synthesis; Dopamine D3 receptor; Locomotor activity; Prepulse inhibition; Stereotyped behaviour

Indexed keywords

3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; APOMORPHINE; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GAMMA BUTYROLACTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030011338     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(96)00179-7     Document Type: Article

References (46)

1. Adler L. E., Pachtman E., Franks R. D., Pecevich M., Waldo M. C. and Freedman R. (1982) Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol. Psychiat. 17: 639-654.
2. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat. Eur. J. Pharmac. 260: 177-181.
3. Bordi F., Carr K. D. and Meller E. (1989) Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens. Brain Res. 489: 205-215.
4. Braff D. L., Stone C., Callaway E., Geyer M. A., Glick I. and Bali L. (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15: 339-343.
5. Brown F., Campbell W., Mitchell P. J. and Randall K. (1985) Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis. Br. J. Pharmac. 84: 853-860.
6. Caine S. B. and Koob G. F. (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260: 1814-1816.
7. 2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology 12: 139-145.
8. Carlsson A., Davis J. N., Kehr W., Lindquist M. and Atack C. V. (1972) Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Archs Pharmac. 275: 153-168.
9. Costall B. and Naylor R. J. (1973) The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour. Eur. J. Pharmac. 24: 8-24.
10. Daly S. A. and Waddington J. L. (1993) Behavioural effects of the putative D-3 dopamine receptor agonist, 7-OH-DPAT in relation to other "D-2-like" agonists. Neuropharmacology 32: 509-510.
11. Damsuma G., Bottema T., Westerink B. H. C., Tepper P. G., Dijkstra D., Pugsley T. A., MacKenzie R. G., Heffner T. G. and Wikstrom H. (1993) Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand. Eur. J. Pharmac. 249: R9-R10.
12. Davis M. (1988) Apomorphine, d-amphetamine, strychinine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex. Psychopharmacology 95: 151-156.
13. Davis M., Mansbach R. S., Swerdlow N. R., Campeau S., Braff D. L. and Geyer M. A. (1990) Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology 102: 1-4.
14. 3 selective compound, PD 128907. Soc. Neurosci. Abst. 19: 77.
15. DeWald H. A., Heffner T. G., Jaen J. C., Lustgarten D. M., McPhail A. T., Meltzer L. T., Pugsley T. A. and Wise L. D. (1990) Synthesis and dopamine agonist properties of (±)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4- oxazin-9ol and its enantiomers. J. Med. Chem. 33: 445-450.
16. DiChiara G., Porceddu M. L., Vargiu L., Argiolas A. and Gessa G. L. (1976) Evidence for dopamine receptors mediating sedation in the mouse brain. Nature 264: 564-565.
17. Dourish C. T. and Hutson P. H. (1985) Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats. Neuropharmacology 24: 1051-1055.
18. Eilam D. and Szechtman H. (1989) Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur. J. Pharmac. 161: 151-157.
19. 3 dopamine receptor. J. Pharmac. Exp. Ther. 268: 417-426.
20. Gower A. J., Berendsen M. M., Princen M. M. and Broekkamp C. L. E. (1984) The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity. Eur. J. Pharmac. 103: 81-89.
21. Hutson P. H., Bristow L. J., Thorn L. and Tricklebank M. D. (1991) R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br. J. Pharmac. 103: 2037-2044.
22. Kelley A. E., Lang C. G. and Gauthier A. M. (1988) Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology 95: 556-559.
23. Kelley A. E., Gauthier A. M. and Lang C. G. (1989) Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behaviour. Behav. Brain Res. 35: 27-39.
24. Kelly P. H., Seviour P. W. and Iversen S. D. (1975) Amphetamine and apomorphine responses in the rat following 6-OH-DA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94: 507-522.
25. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 5: 145-153.
26. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Eur. J. Pharmac. 275: R7-R9.
27. 3H]hydroxy-N-N-di-n-propyl-2-aminotetralin. Proc. Natn. Acad. Sci. USA 89: 8155-8159.
28. Ljungberg T. and Ungerstedt U. (1976) Automatic registration of behaviour related to dopamine and noradrenaline transmission. Eur. J. Pharmac. 36: 181-188.
29. Mansbach R. S., Geyer M. A. and Braff D. L. (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94: 507-514.
30. 3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats. Eur. J. Pharmac. 260: R3-R5.
31. Murray A. M. and Waddington J. L. (1989) Further evidence for two directions of D-1: D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502. Psychopharmacology 98: 245-250.
32. 3 receptor. Br. J. Pharmac. 114: 347P.
33. Rivet J. M., Audinot V., Gobert A., Peglion J. L. and Millan M. J. (1994) Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297. Eur. J. Pharmac. 265: 175-177.
34. 2 receptors. Neuroreport 6: 329-332.
35. 3 receptor agonist, (+)-PD 128907, on prepulse inhibition in the rat. Br. J. Pharmac. 112: 508P.
36. Snyder S. H. (1990) The dopamine connection. Nature 347: 121-122.
37. 3) as a target for neuroleptics. Nature 347: 146-151.
38. 2 receptor. Eur. J. Pharmac. 225: 331-337.
39. Svensson K., Johansson A. M., Magnusson T. and Carlsson A. (1986) (+)-AJ 76 and (+)-UH 232: Central stimulants acting as preferential dopamine autoreceptor antagonists. Naunyn-Schmiedeberg's Archs Pharmac. 334: 234-245.
40. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J. Neural Transm. [GenSect] 95: 71-74.
41. Swerdlow N. R., Braff D. L., Geyer M. A. and Koob G. F. (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiat. 21: 23-33.
42. Swerdlow N. R., Braff D. L., Masten V. L. and Geyer M. A. (1990) Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101: 414-420.
43. Swerdlow N. R., Keith V. A., Braff D. L. and Geyer M. A. (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J. Pharm. Exp. Ther. 256: 530-536.
44. Waddington J. L. and O'Boyle K. M. (1989) Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. Pharmac. Ther. 43: 1-52.
45. Wan F. J. and Swerdlow N. R. (1993) Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology 113: 103-109.
46. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J. Neural Transm. [GenSect] 94: 11-19.